… ts without a functioning pacemaker.
• Severe bradycardia (less than 50 beats per minute).
• Left ventricular failure with pulmonary stasis.
• Decompensated cardiac failure.
• Lactation.
• Concurrent use with dantrolene infusion (see section 4.5).
• Combination with ivabradine (see section 4.5).
• Concurrent use with lomitapide (see section 4.5).
• Concurrent use with asunaprevir (see section 4.5).
Identical in all 3 labels. Surrounding text shown from Ethypharm UK Ltd.
… pacemaker. • Second- or third-degree AV block except in the presence of a functioning ventricular pacemaker. • Severe bradycardia (below 40 bpm) • Left ventricular failure with pulmonary congestion • Concomitant use of dantrolene infusion (see section 4.5). • Additionally, for the intravenous forms, patients known to have an accessory bypass (Wolf-Parkinson-White syndrome or short PR syndrome), and who develop atrial fibrillation or flutter, should not …
Identical in all 3 labels. Surrounding text shown from Zentiva.
… with severe bradycardia (less than 40 bpm), second or third degree heart block, sick sinus syndrome, decompensated cardiac failure, patients with left ventricular failure with pulmonary congestion.
Concurrent use with dantrolene infusion because of the risk of ventricular fibrillation (see section 4.5).
Hypersensitivity to diltiazem or to any of the excipients.
Concurrent use with lomitapide (see section 4.5).
Identical in both labels. Surrounding text shown from Napp Pharmaceuticals Limited.
…
Diltiazem is contraindicated in pre-excitation syndrome (e.g. WPW) accompanied with atrial flutter, fibrillation and in digitalis intoxication, as diltiazem may precipitate ventricular tachycardia.
Diltiazem is contraindicated in combination with ivabradine (see section 4.5)
Diltiazem should not be used in patients with known hypersensitivity to diltiazem.
Diltiazem should not be used during pregnancy, by women of child-bearing potential, or by women who are breastfeed …
Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Diltiazem is contraindicated in patients with severe bradycardia (below 40 bpm); in sick sinus syndrome or in second- or third-degree AV block, in patients without a functioning pacemaker; in left ventricular failure with pulmonary congestion. Diltiazem should not be given concomitantly with dantrolene infusion (see section 4.5). Diltiazem is also contraindicated in combination with ivabradine (see section 4.5). Diltiazem should not be used concurrently with lomitapide (see section 4.5).
Diltiazem is contraindicated in pregnancy, in women of childbearing potential not using effective contraception and while breast-feeding (see section 4.6).
Taken with other medicines · Diltiazem · Interchangeable?